Microport – Firehawk® Rapamycin Target Eluting Coronary Stent System

Firehawk® Rapamycin Target Eluting Coronary Stent System is the World’s First and Only Target Eluting Stent (TES), which is the new generation product of Shanghai MicroPort Medical (Group) Co., Ltd. following the Firebird and Firebird2 stent to treat coronary artery stenosis or occlusion disease.

COBRA PzF NanoCoated Coronary Stent (NCS)

The revolutionary COBRA PzF NCS is a new nanocoated, non drug-eluting stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.

TRYTON Side Branch Stent

The Tryton Side Branch Stent is deployed in the side branch artery using a standard single-wire, balloon-expandable stent delivery system. The open architecture of the Tryton stent allows for integration of a conventional drug eluting stent for the main vessel.

Envision Scientific – Abluminus DES+

The Abluminus DES+ is a product of envisolution Technology which is designed to treat diabetic patients.

Envisolution technology is a combination of highly effective drug delivery with target specificcoating technology. It is a biodegradable polymer based drug delivery technology. Abluminus (DES+) sirolimus eluting coronary stent system is a product of Envisolution Technology.

The Envisolution Technology Was Designed Considering Following Mentioned Concerns
• Delayed Healing with poor endothelialisation
• Acute/Sub acute/Late Thrombosis In Coronary Artery
• Restenosis Patterns Focal/Edge/Proximal
• Dose Of Drug/Polymer